Theralase Technologies Inc. (TLT) | WebDisclosure

Basculer en Français

8302	Companies
115129	Keywords
55450	Articles
62533	Press releases

Headlines Articles Press releases Theralase Technologies Inc.

Home
Companies
Theralase Technologies Inc.

BRIEF

published on 04/05/2024 at 13:05, 7 months 16 days ago

Theralase Technologies Inc. reçoit un brevet canadien pour un vaccin contre le cancer

Theralase Technologies Inc. Vaccin Contre Le Cancer Études Cliniques Composés Photodynamiques Cancers Liquides
BRIEF

published on 04/05/2024 at 13:05, 7 months 16 days ago

Theralase Technologies Inc. Receives Canadian Patent for Cancer Vaccine

Theralase Technologies Inc. Cancer Vaccine Photo Dynamic Compounds Liquid Cancers Clinical Studies
PRESS RELEASE

published on 04/05/2024 at 13:00, 7 months 16 days ago

Theralase(R) Granted Canadian Cancer Vaccine Patent
Theralase Technologies Inc. secures Canadian patent for new cancer vaccine using Photodynamic Compounds (PDCs). Plans for clinical studies on bladder, brain, and lung cancers. Expansion to treat 'liquid cancers'

Theralase Technologies Inc. Cancer Vaccine Liquid Cancers Clinical Studies Photodynamic Compounds
BRIEF

published on 03/27/2024 at 12:05, 7 months 25 days ago

Theralase Technologies Inc. publie ses résultats financiers pour l'exercice 2023

Résultats Financiers Placement Privé RuvidarTM Technologies Théralase Mise À Jour De L'étude II
BRIEF

published on 03/27/2024 at 12:05, 7 months 25 days ago

Theralase Technologies Inc. Reports Financial Results for Fiscal Year 2023

Private Placement Financial Results Theralase Technologies RuvidarTM Study II Update
PRESS RELEASE

published on 03/27/2024 at 12:00, 7 months 25 days ago

Theralase(R) Release's 4Q2023 Interim Financial Statements
Theralase Technologies Inc. releases audited 2023 financial statements and plans conference call to discuss fiscal year results. Company highlights financial performance and updates on clinical Study II progress

Conference Call Financial Statements Theralase Technologies Inc. Fiscal Year Results Clinical Study II
BRIEF

published on 03/26/2024 at 12:05, 7 months 26 days ago

Theralase to Present Interim Clinical Data at Upcoming Urological Forums

Patient Recruitment Clinical Study Theralase Bladder Cancer Photodynamic Therapy
BRIEF

published on 03/26/2024 at 12:05, 7 months 26 days ago

Theralase présentera des données cliniques provisoires lors des prochains forums urologiques

Étude Clinique Theralase Cancer De La Vessie La Thérapie Photodynamique Recrutement De Patients
PRESS RELEASE

published on 03/26/2024 at 12:00, 7 months 26 days ago

Theralase(R) to Host Advisory Board Meetings at Canadian Urological Association Bladder Cancer Forum and the American Urological Association
Theralase Technologies Inc. to present latest Study II interim clinical data on Ruvidar™-based photodynamic therapy for BCG-Unresponsive NMIBC CIS at upcoming Advisory Board meetings in Toronto and San Antonio

Theralase Technologies Inc. Photodynamic Therapy Study II Ruvidar BCG-Unresponsive NMIBC CIS
PRESS RELEASE

published on 02/12/2024 at 13:00, 9 months 9 days ago

Theralase(R) Donates Cool Laser Therapy Technology to Aid in Research and Development of a Treatment for Parkinson's Disease
Theralase® donates CLT systems to aid in Parkinson's Disease research at University of Windsor

Research Parkinson's Disease Theralase® CLT Systems University Of Windsor

Accesswire

Published on 11/22/2024 at 00:00, 3 hours 30 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 5 hours 25 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 5 hours 40 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 7 hours 15 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 7 hours 20 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 8 hours 29 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 8 hours 54 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 9 hours 31 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 9 hours 38 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 9 hours 38 minutes ago

LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris.

Les Echos

Published on 11/21/2024 at 06:58, 20 hours 32 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 20 hours 32 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 20 hours 32 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 7 hours ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 8 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE